# A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema

> **NCT00135655** · PHASE2 · WITHDRAWN · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Macular Edema, Cystoid

## Interventions

- **DRUG:** denufosol tetrasodium (INS37217) Intravitreal Injection

## Key facts

- **NCT ID:** NCT00135655
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135655, "A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00135655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*